Trial NCT00177138

View at ClinicalTrials.gov 
Org. Study IDs: 0308M51264
Secondary IDs: Berlex Study No. 107.G0001

Last trial update was posted on 2013-02-07

MeSH Interventions

Alemtuzumab Tacrolimus

MeSH Conditions


Other Conditions

Diabetes Mellitus

Stopping Reasons

The clinical use of Campath for transplant patients was temporarily suspended.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID